Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-321N4.5 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | RNASE3 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | TRIM65 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
mRNA | RHD | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
mRNA | TOPORS-AS1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | VIM | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
mRNA | FCRLA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | IL1R1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | STYXL1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
mRNA | DLX4 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |